Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MR DNA is a private life-science tools and services company that operates as Molecular Research LP and provides next-generation sequencing and bioinformatics services. The company focuses on microbiome profiling, shotgun metagenomics, whole-genome sequencing, RNA-seq/transcriptomics, targeted sequencing, and custom molecular assay development for research customers. Its offerings are positioned as end-to-end services spanning study design support, wet-lab sequencing workflows, data analysis, QC, and publication-ready reporting. MR DNA appears to serve academic, clinical, environmental, agriculture, and biotech/pharma research programs rather than developing its own therapeutic drug pipeline. The business is therefore best characterized as a commercial genomics CRO/service provider rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MR DNA.